Prognostic value of proton magnetic resonance spectroscopy in ischemic stroke

Archives of Neurology

Volumn 55, Issue 4, 1998, Pages 489-494

  Federico, Francesco ^a   Simone, Isabella Laura ^a   Lucivero, Vincenzo ^a   Giannini, Paolo ^a   Laddomada, Giuseppe ^a   Mezzapesa, Domenico Maria ^a   Tortorella, Carla ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN SCINTISCANNING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LINEAR MODELS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROGNOSIS; PROTONS; TREATMENT OUTCOME;

EID: 0031918720     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.4.489     Document Type: Article

References (30)

1. Bryan RN, Levy LM, Writlow WD, Killian JM, Preziosi TJ, Rosario JA. Diagnosis of acute cerebral infarction: comparison of CT and MR imaging. AJNR Am J Neuroradiol. 1991;12:611-620.
2. Fisher M, Sotak CH, Minematsu K, Li L. New magnetic resonance techniques for evaluating cerebrovascular disease. Ann Neurol. 1992;32:115-122.
3. Warach S, Chien D, Li W, Ronthal MB, Edelman RR. Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology. 1992;42:1717-1723.
4. Duijn JH, Matson GB, Maudsley AA, Hugg JW, Weiner MW. Human brain infarction: proton MR spectroscopy. Radiology. 1992;183:711-718.
5. 1H-MRS of stroke. Neurology. 1992;42:1408-1412.
6. Gideon P, Henriksen O, Sperling B, et al. Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. Stroke. 1992;23:1566-1572.
7. Petroff OAC, Graham GD, Blamire AM, et al. Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology. 1992;42: 1349-1354.
8. Houkin K, Kamada K, Kamiyama H, Iwasaki Y, Abe H, Kashiwaba T. Longitudinal changes in proton magnetic resonance spectroscopy in cerebral infarction. Stroke. 1993;24:1316-1321.
9. Barker PB, Gillard JH, van Zijl PCM, et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology. 1994;192:723-732.
10. Federico F, Simone IL, Conte C, et al. Prognostic significance of metabolic changes detected by proton magnetic resonance spectroscopy in ischaemic stroke. J Neurol. 1996;243:241-247.
11. Graham GD, Kalvach P, Blamire A, Brass LM, Fayad PB, Prichard JW. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarctions. Stroke. 1995;26:225-229.
12. Lanferman H, Kugel H, Heindel W, Herholz K, Heiss WD, Lackner K. Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging. Radiology. 1995;196:203-210.
13. Saunders DE, Howe FA, van den Boogart A, McLean MA, Griffiths JR, Brown MM. Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke. 1995;26:1007-1013.
14. Gillard JH, Barker PB, van Zijl PCM, Bryan RN, Oppenheimer SM. Proton MR spectroscopy in acute middle cerebral artery stroke. AJNR Am J Neuroradiol. 1996;17:873-886.
15. 1H-MRS and diffusion weighted MR image. Proc Soc Magn Reson Med. 1993;12: 1488. Abstract.
16. 1H magnetic resonance spectroscopy in rats. Neurosurgery. 1996;38:121-129.
17. Graham GD, Blamire AM, Rothman DL, et al. Temporal variation of cerebral metabolites after human stroke: a proton magnetic resonance spectroscopy study. Stroke. 1993;24:1891-1896.
18. Prichard JW. MRS of the brain: prospect for clinical application. In: Young IR, Charles HC, eds. MR Spectroscopy. London, England: Martin Dunib Ltd; 1996:5.
19. Gideon P, Sperling B, Arlien-Soborg P, Olsen TS, Henriksen O. Long-term follow up of cerebral infarction patients with proton magnetic resonance spectroscopy. Stroke. 1994;25:867-973.
20. De Haan R, Horn J, Limburg M, van der Meulen J, Bossuyt P. A comparison of five stroke scales with measures of disability, handicap and quality of life. Stroke. 1993;24:1178-1181.
21. Scandinavian Stroke Study Group. Multicentre trial of hemodilution in ischemic stroke: background and study protocol. Stroke. 1985;16:885-890.
22. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized H-NMR spectroscopy in different regions of the human brain in vivo: relaxation times and concentrations of cerebral metabolites. Magn Reson Med. 1989;11: 47-63.
23. 1H-NMR spectra of human brain in vivo. NMR Biomed. 1991;4:90-98.
24. Federico F, Conte C, Simone IL, et al. Proton magnetic resonance spectroscopy in patients with ischemic stroke. Ital J Neurol Sci. 1994;15:413-420.
25. Felber SR, Aichner FT, Sauter R, Gerstenbrand F. Combined magnetic resonance imaging and proton magnetic resonance spectroscopy of patients with acute stroke. Stroke. 1992;23:1106-1110.
26. Fenstermacher MJ, Narayana PA. Serial proton magnetic resonance spectroscopy of ischemic brain injury in humans. Invest Radiol. 1990;25:1034-1039.
27. Mathews VP, Barker PB, Blackband SJ, Chatham JC, Bryan RN. Cerebral metabolites in patients with acute and subacute strokes: concentrations determined by quantitative proton MR spectroscopy. AJR Am J Roentgenol. 1995; 165:633-638.
28. 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev. 1989;12:23-31.
29. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience. 1991;45:37-45.
30. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 1993;13:981-989.